多普泰 (831057.OC)

+ 收藏

主营构成(按产品)(多普泰)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年中报2024年年报2024年中报2023年年报2023年中报
营业收入(元)
 脉血康胶囊(元) -105,262,137.6384,837,146.14456,825,395.12202,448,142.79
 脉血康片剂(元) -5,378,008.282,676,091.6016,483,665.496,218,309.50
 晕痛定胶囊(元) 23,206,027.3946,294,942.2821,685,509.3656,664,542.8628,231,094.17
 八珍袋泡茶(元) 24,434,473.61----
 乌贝胶囊/颗粒(元) 31,027,644.99----
 其他品种(元) 30,706,933.0093,471,619.7437,174,892.8414,153,099.625,253,744.13
营业成本(元)
 脉血康胶囊(元) -62,694,716.8146,078,304.2782,466,670.4038,053,934.38
 脉血康片剂(元) -7,882,398.594,353,206.306,339,477.362,147,231.59
 晕痛定胶囊(元) 5,792,101.8910,141,521.925,226,096.9813,609,159.166,913,608.79
 八珍袋泡茶(元) 3,399,248.47----
 乌贝胶囊/颗粒(元) 2,798,488.00----
 其他品种(元) 8,374,294.6613,149,455.064,019,913.005,384,594.032,206,979.11
毛利(元)
 脉血康胶囊(元) -42,567,420.8238,758,841.87374,358,724.72164,394,208.41
 脉血康片剂(元) --2,504,390.31-1,677,114.7010,144,188.134,071,077.91
 晕痛定胶囊(元) 17,413,925.5036,153,420.3616,459,412.3843,055,383.7021,317,485.38
 八珍袋泡茶(元) 21,035,225.14----
 乌贝胶囊/颗粒(元) 28,229,156.99----
 其他品种(元) 22,332,638.3480,322,164.6833,154,979.848,768,505.593,046,765.02
毛利率(%)
 脉血康胶囊(%) -40.4445.6981.9581.20
 脉血康片剂(%) --46.57-62.6761.5465.47
 晕痛定胶囊(%) 75.0478.0975.9075.9875.51
 八珍袋泡茶(%) 86.09----
 乌贝胶囊/颗粒(%) 90.98----
 其他品种(%) 72.7385.9389.1961.9557.99
收入构成(%)
 脉血康胶囊(%) -42.0457.9683.9683.60
 脉血康片剂(%) -2.151.833.032.57
 晕痛定胶囊(%) 21.2218.4914.8210.4111.66
 八珍袋泡茶(%) 22.34----
 乌贝胶囊/颗粒(%) 28.37----
 其他品种(%) 28.0737.3325.402.602.17
毛利构成(%)
 脉血康胶囊(%) -27.1944.7185.8085.25
 脉血康片剂(%) --1.60-1.932.322.11
 晕痛定胶囊(%) 19.5623.1018.999.8711.06
 八珍袋泡茶(%) 23.63----
 乌贝胶囊/颗粒(%) 31.71----
 其他品种(%) 25.0951.3138.242.011.58

前瞻产业研究院